Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126817311 | 12681731 | 1 | I | 2012 | 20160816 | 20160824 | 20160824 | EXP | FR-INDIVIOR LIMITED-INDV-093912-2016 | INDIVIOR | 40.00 | YR | M | Y | 0.00000 | 20160824 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126817311 | 12681731 | 1 | PS | SUBUTEX | BUPRENORPHINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 4MG PER DAY FOR 4 YEARS | Y | UNKNOWN | 20732 | SUBLINGUAL TABLET | |||||||
126817311 | 12681731 | 2 | SS | SKENAN | MORPHINE SULFATE | 1 | Intravenous (not otherwise specified) | 600 MG, DAILY | Y | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126817311 | 12681731 | 1 | Product used for unknown indication |
126817311 | 12681731 | 2 | Pain |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126817311 | 12681731 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126817311 | 12681731 | Arthritis bacterial | |
126817311 | 12681731 | Intentional product use issue | |
126817311 | 12681731 | Osteonecrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126817311 | 12681731 | 1 | 2012 | 2016 | 0 | |
126817311 | 12681731 | 2 | 2016 | 2016 | 0 |